TerrAscend Missed Consensus Estimates

TerrAscend (TSNDF) reported a loss of $0.04 per share on revenue of $67.12 million for the second quarter ended June 2026. The consensus estimate was a loss of $0.02 per share. The company missed consensus estimates by 100.00% while revenue grew 3.25% on a year-over-year basis.

TerrAscend is a cannabis operator with vertically integrated operations principally in Pennsylvania, New Jersey and California, licensed cultivation and processing operations in Maryland and licensed production in Canada. The Company owns several synergistic businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. TerrAscend is based in NEW YORK.